Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets

[1]  G. Fuller,et al.  Central Nervous System , 2007 .

[2]  C. Dunphy,et al.  Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. , 2006, Archives of pathology & laboratory medicine.

[3]  V. P. Collins,et al.  Clonal Genomic Alterations in Glioma Malignancy Stages 1 , 2006 .

[4]  Koji Yoshimoto,et al.  Distinct transcription profiles of primary and secondary glioblastoma subgroups. , 2006, Cancer research.

[5]  Erik K. Malm,et al.  A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.

[6]  M. Berger,et al.  Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. , 2005, Journal of the National Cancer Institute.

[7]  J. Bowsher,et al.  Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  M. Weller,et al.  HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo. , 2005, Journal of neuropathology and experimental neurology.

[9]  Benjamin Georgi,et al.  BIOINFORMATICS APPLICATIONS NOTE Gene expression MACAT—microarray chromosome analysis tool , 2022 .

[10]  Daniel J Brat,et al.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.

[11]  Yu Shyr,et al.  Coupled analysis of gene expression and chromosomal location. , 2005, Genomics.

[12]  P. Kleihues,et al.  Epidemiology and etiology of gliomas , 2005, Acta Neuropathologica.

[13]  Catrin Bauréus Koch,et al.  Immunization with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in GBM-patients older than 50 years , 2005 .

[14]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.

[15]  Sun-Yuan Kung,et al.  Accurate detection of aneuploidies in array CGH and gene expression microarray data , 2004, Bioinform..

[16]  N. Stitziel,et al.  Membrane-Associated and Secreted Genes in Breast Cancer , 2004, Cancer Research.

[17]  Paul Kremer,et al.  Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Catherine A. Ball,et al.  Caryoscope: An Open Source Java application for viewing microarray data in a genomic context , 2004, BMC Bioinformatics.

[19]  M. Weller,et al.  The Innate Immune Response in the Central Nervous System and Its Role in Glioma Immune Surveillance , 2004, Oncology Research and Treatment.

[20]  S. Nelson,et al.  DNA-microarray analysis of brain cancer: molecular classification for therapy , 2004, Nature Reviews Neuroscience.

[21]  Johan Staaf,et al.  ACID: a database for microarray clone information , 2004, Bioinform..

[22]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[23]  A. Abulrob,et al.  Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae , 2004, Oncogene.

[24]  G. Reifenberger,et al.  Pathology and molecular genetics of astrocytic gliomas , 2004, Journal of Molecular Medicine.

[25]  Daniel J Brat,et al.  Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. , 2004, The international journal of biochemistry & cell biology.

[26]  M. Varla-Leftherioti,et al.  Role of a KIR/HLA-C allorecognition system in pregnancy. , 2004, Journal of reproductive immunology.

[27]  M. Berger,et al.  Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors , 2003, Journal of Neuro-Oncology.

[28]  M. Samii,et al.  CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma , 1999, Clinical & Experimental Metastasis.

[29]  M. Katoh WNT2 and human gastrointestinal cancer (review). , 2003, International journal of molecular medicine.

[30]  Eytan Domany,et al.  Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. , 2003, Cancer research.

[31]  M. Westphal,et al.  A role for receptor tyrosine phosphataseζ in glioma cell migration , 2003, Oncogene.

[32]  Susan M. Chang,et al.  Grade II astrocytomas are subgrouped by chromosome aberrations. , 2003, Cancer genetics and cytogenetics.

[33]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[34]  M. Westphal,et al.  A role for receptor tyrosine phosphatase zeta in glioma cell migration. , 2003, Oncogene.

[35]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Gruvberger,et al.  BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data , 2002, Genome Biology.

[37]  R. Eils,et al.  Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. , 2002, Cancer research.

[38]  Javed Khan,et al.  Gene expression profiling in cancer using cDNA microarrays. , 2002, Methods in molecular medicine.

[39]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[40]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[41]  K. Adamsky,et al.  Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C , 2001, Oncogene.

[42]  M. Brada Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.

[43]  K. Adamsky,et al.  Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C. , 2001, Oncogene.

[44]  E. Musgrove,et al.  The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle , 2000, The Journal of physiology.

[45]  Jonathan Pevsner,et al.  DRAGON: Database Referencing of Array Genes Online , 2000, Bioinform..

[46]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays , 1999, Nature Genetics.

[47]  W. Yung,et al.  Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.

[48]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.

[49]  M. Diehn Large-scale identification of secreted and membrane-associated gene products using DNA microarrays , 1999, Nature Genetics.

[50]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[51]  E. Hudson,et al.  Met and hepatocyte growth factor/scatter factor expression in human gliomas. , 1997, Cancer research.

[52]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[53]  D. Bigner,et al.  Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[55]  O. Silvennoinen,et al.  The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. , 1993, The Journal of biological chemistry.

[56]  L. Salford,et al.  Ten-year survival among patients with supratentorial astrocytomas grade III and IV. , 1988, Journal of neurosurgery.

[57]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[58]  D. Bigner,et al.  Specific chromosomal abnormalities in malignant human gliomas. , 1988, Cancer research.

[59]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[60]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[61]  John W. Sammon,et al.  A Nonlinear Mapping for Data Structure Analysis , 1969, IEEE Transactions on Computers.